Related Experiment Video
Updated: Feb 8, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases
Alicja Derkacz1, Pawel Olczyk2, Katarzyna Komosinska-Vassev1
1Department of Clinical Chemistry and Laboratory Diagnostics, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8, 41-200 Sosnowiec, Poland.
This study reviews laboratory biomarkers for inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). These noninvasive markers aid in diagnosis, disease activity assessment, and treatment selection for IBD patients.
Area of Science:
- Gastroenterology
- Immunology
- Biomarker Discovery
Background:
- Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal inflammatory conditions with unclear etiology.
- Current diagnosis and management of IBD rely on a multidisciplinary approach, including clinical, laboratory, endoscopic, and histologic evaluations.
- Genetic, immune, and environmental factors are implicated in IBD pathogenesis.
Purpose of the Study:
- To present an overview of laboratory biomarkers for diagnosing and managing IBD.
- To highlight the role of noninvasive biomarkers in improving diagnostic accuracy and specificity for IBD.
- To discuss biomarkers for differentiating IBD from functional disorders and assessing disease activity, prognosis, and treatment response.
Main Methods:
- Review of existing literature on laboratory biomarkers in inflammatory bowel diseases.
- Focus on noninvasive biomarkers for enhanced diagnostic capabilities.
- Analysis of biomarker utility in disease activity assessment, risk stratification, and predicting treatment outcomes.
Main Results:
- Development of noninvasive biomarker panels has significantly improved diagnostic sensitivity and specificity for IBD.
- Laboratory biomarkers are crucial for differentiating IBD from functional gastrointestinal disorders.
- Specific biomarkers aid in evaluating disease activity, prognosis, and guiding treatment selection in IBD.
Conclusions:
- Noninvasive laboratory biomarkers represent a valuable addition to the multidisciplinary approach for IBD management.
- These biomarkers enhance the ability to accurately diagnose, monitor disease activity, and personalize treatment for IBD patients.
- Continued research into novel biomarkers holds promise for further advancing IBD care.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: